Integrated adherence monitors in asthma and COPD inhalers are on the horizon and clinicians should do all they can to support their development and adoption. A call-to-action, published in JAMA in response to recent FDA approval of the first such inhaler – Teva’s ProAir Digihaler (albuterol sulfate 117mcg) – said integrated adherence monitoring was ‘desirable, feasible ...
Digital inhalers to report patient adherence
By Mardi Chapman
14 Mar 2019